日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Successful Recovery from Severe Fever with Thrombocytopenia Syndrome and Hemophagocytic Lymphohistiocytosis with Standard Treatment and a Calcium Channel Blocker of Nicardipine Hydrochloride

通过标准治疗和钙通道阻滞剂盐酸尼卡地平,成功治愈了伴有血小板减少综合征和噬血细胞性淋巴组织细胞增生症的严重发热患者。

Yamauchi, Nao; Hongo, Takashi; Kawakami, Manri; Inoguchi, Kyosuke; Oguni, Syunsuke; Momoki, Noriya; Ueno, Akiko; Ikeda, Fusao; Fujioka, Shinichi; Yamamoto, Kazuhide

Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study

雷迪帕韦和索非布韦治疗慢性丙型肝炎病毒2型基因感染患者的真实世界病毒学疗效和安全性:一项多中心研究

Tada, Toshifumi; Kumada, Takashi; Okushin, Hiroaki; Tani, Joji; Takaguchi, Koichi; Tsutsui, Akemi; Toyoda, Hidenori; Yasuda, Satoshi; Dohmen, Kazufumi; Hiraoka, Atsushi; Michitaka, Kojiro; Nouso, Kazuhiro; Kariyama, Kazuya; Kim, Soo Ryang; Kim, Soo Ki; Fujioka, Shinichi; Mikami, Shigeru; Watanabe, Yuto; Tamai, Tsutomu; Atsukawa, Masanori; Itokawa, Norio; Tanaka, Hironori; Tsuji, Kunihiko; Ishikawa, Toru; Imai, Michitaka; Itobayashi, Ei; Shibata, Hiroshi; Shimada, Noritomo

Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study.

12 周索非布韦/维帕他韦治疗失代偿期肝硬化基因 1 型和 2 型患者的真实世界临床应用:一项前瞻性多中心研究

Atsukawa Masanori, Tsubota Akihito, Kondo Chisa, Toyoda Hidenori, Nakamuta Makoto, Takaguchi Koichi, Watanabe Tsunamasa, Hiraoka Atsushi, Uojima Haruki, Ishikawa Toru, Iwasa Motoh, Tada Toshifumi, Nozaki Akito, Chuma Makoto, Fukunishi Shinya, Asai Akira, Asano Toru, Ogawa Chikara, Abe Hiroshi, Hotta Naoki, Shima Toshihide, Iio Etsuko, Mikami Shigeru, Tachi Yoshihiko, Fujioka Shinichi, Okubo Hironao, Shimada Noritomo, Tani Joji, Hidaka Isao, Moriya Akio, Tsuji Kunihiko, Akahane Takehiro, Yamashita Naoki, Okubo Tomomi, Arai Taeang, Morita Kiyoshi, Kawata Kazuhito, Tanaka Yasuhito, Okanoue Takeshi, Maeda Shin, Kumada Takashi, Iwakiri Katsuhiko

Trends and Efficacy of Interferon-Free Anti-hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan

日本高发老年患者、肝硬化和肝细胞癌地区无干扰素抗丙型肝炎病毒疗法的趋势和疗效:一项纳入10688例患者的真实世界、全国性、多中心研究

Toyoda, Hidenori; Atsukawa, Masanori; Uojima, Haruki; Nozaki, Akito; Tamai, Hideyuki; Takaguchi, Koichi; Fujioka, Shinichi; Nakamuta, Makoto; Tada, Toshifumi; Yasuda, Satoshi; Chuma, Makoto; Senoh, Tomonori; Tsutsui, Akemi; Yamashita, Naoki; Hiraoka, Atsushi; Michitaka, Kojiro; Shima, Toshihide; Akahane, Takehiro; Itobayashi, Ei; Watanabe, Tsunamasa; Ikeda, Hiroki; Iio, Etsuko; Fukunishi, Shinya; Asano, Toru; Tachi, Yoshihiko; Ikegami, Tadashi; Tsuji, Kunihiko; Abe, Hiroshi; Kato, Keizo; Mikami, Shigeru; Okubo, Hironao; Shimada, Noritomo; Ishikawa, Toru; Matsumoto, Yoshihiro; Itokawa, Norio; Arai, Taeang; Tsubota, Akihito; Iwakiri, Katsuhiko; Tanaka, Yasuhito; Kumada, Takashi

Clinical features of hemodialysis patients treated for hepatocellular carcinoma: Comparison between resection and radiofrequency ablation

接受血液透析治疗的肝细胞癌患者的临床特征:切除术与射频消融术的比较

Hiraoka, Atsushi; Kumada, Takashi; Michitaka, Kojiro; Toyoda, Hidenori; Tada, Toshifumi; Takaguchi, Koichi; Tsuji, Kunihiko; Itobayashi, Ei; Takizawa, Daichi; Hirooka, Masashi; Koizumi, Yohei; Ochi, Hironori; Joko, Koji; Kisaka, Yoshiyasu; Shimizu, Yuko; Tajiri, Kazuto; Tani, Joji; Taniguchi, Tatsuya; Toshimori, Akiko; Fujioka, Shinichi